Han Xiang Y, Dé Indra, Jacobson Kalen L
Clinical Microbiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Am J Clin Pathol. 2007 Oct;128(4):612-21. doi: 10.1309/1KB2GKYT1BUEYLB5.
We analyzed clinical and microbiologic features of 115 cases involving rapidly growing mycobacteria (RGM) isolated at the University of Texas M.D. Anderson Cancer Center, Houston (2000-2005) and identified by 16S ribosomal RNA gene sequencing analysis. At least 15 RGM species were included: Mycobacterium abscessus (43 strains [37.4%]), Mycobacterium fortuitum complex (33 strains [28.7%]), and Mycobacterium mucogenicum (28 strains [24.3%]) most common, accounting for 90.4%. Most M abscessus (32/43) were isolated from respiratory sources, whereas most M mucogenicum (24/28) were from blood cultures. Antimicrobial susceptibility tests showed that M abscessus was the most resistant species; M mucogenicum was most susceptible. From blood and catheter sources, 46 strains (40.0%) were isolated; 44 represented bacteremia or catheter-related infections. These infections typically manifested high fever (mean temperature, 38.9 degrees C), with a high number of RGM colonies cultured. All infections resolved with catheter removal and antibiotic therapy. Six strains (M abscessus and M fortuitum only) were from skin, soft tissue, and wound infections. There were 59 strains from respiratory sources, and 28 of these represented definitive to probable infections. Prior lung injuries and coisolation of other pathogenic organisms were common. Overall, 78 RGM strains (67.8%) caused true to probable infections without direct deaths.
我们分析了115例涉及快速生长分枝杆菌(RGM)病例的临床和微生物学特征,这些病例于2000年至2005年在休斯顿的德克萨斯大学MD安德森癌症中心分离得到,并通过16S核糖体RNA基因测序分析进行鉴定。至少包括15种RGM菌种:脓肿分枝杆菌(43株[37.4%])、偶然分枝杆菌复合群(33株[28.7%])和产黏液分枝杆菌(28株[24.3%])最为常见,占90.4%。大多数脓肿分枝杆菌(32/43)从呼吸道来源分离得到,而大多数产黏液分枝杆菌(24/28)从血培养中分离得到。药敏试验表明脓肿分枝杆菌是耐药性最强的菌种;产黏液分枝杆菌最敏感。从血液和导管来源分离出46株(40.0%);44株代表菌血症或导管相关感染。这些感染通常表现为高热(平均体温38.9摄氏度),培养出大量RGM菌落。所有感染通过拔除导管和抗生素治疗得以解决。6株(仅脓肿分枝杆菌和偶然分枝杆菌)来自皮肤、软组织和伤口感染。有59株来自呼吸道来源,其中28株代表确诊或可能的感染。既往肺部损伤和其他致病生物的共同分离很常见。总体而言,78株RGM菌株(67.8%)导致确诊或可能的感染,无直接死亡病例。